Vol 70, No 1 (2019)
Original paper
Published online: 2018-09-27

open access

Page views 3182
Article views/downloads 1501
Get Citation

Connect on Social Media

Connect on Social Media

Sexual function and depressive symptoms in men with overt hyperthyroidism

Robert Krysiak1, Bogdan Marek23, Bogusław Okopień1
Pubmed: 30307028
Endokrynol Pol 2019;70(1):64-71.


Introduction: Although hyperthyroidism is characterised by female predominance, its presence may lead to the development of numerous complications in both sexes. This study was aimed at investigating sexual function and depressive symptoms in men with overt hyperthyroidism of autoimmune and non-autoimmune origin.

Material and methods: The study population consisted of three age-matched groups: men with overt hyperthyroidism and Graves’ disease (group A; n = 20), men with overt hyperthyroidism and toxic multinodular goitre or toxic adenoma (group B; n = 21), and men with normal thyroid function (group C; n = 23). As well as measuring serum hormone levels and antibody titres, and determining calculated parameters of thyroid homeostasis, all included patients filled in questionnaires evaluating sexual function (International Index of Erectile
Function-15: IIEF-15) and assessing the presence and severity of depressive symptoms (Beck Depression Inventory-Second Edition – BDI-II).

Results: Compared with control subjects, men with overt hyperthyroidism obtained lower scores for erectile function, intercourse satisfaction, orgasmic function and overall satisfaction. Scores for erectile function, orgasmic function, and sexual desire differed between both groups of men with thyroid hyperfunction and inversely correlated with thyrotropin receptor antibody titres. The BDI-II score was higher in patients with Graves’ disease than in men with normal thyroid function.

Conclusions: The obtained results indicate that overt hyperthyroidism in men causes multidimensional impairment of sexual function, which is particularly pronounced if excessive hormone production results from Graves’ disease. 

Article available in PDF format

View PDF Download PDF file


  1. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016; 26(10): 1343–1421.
  2. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002; 87(2): 489–499.
  3. Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, et al. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014; 99(3): 923–931.
  4. Kravets I. Hyperthyroidism: Diagnosis and Treatment. Am Fam Physician. 2016; 93(5): 363–370.
  5. De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016; 388(10047): 906–918.
  6. Devereaux D, Tewelde SZ. Hyperthyroidism and thyrotoxicosis. Emerg Med Clin North Am. 2014; 32(2): 277–292.
  7. Cihan A, Demir O, Demir T, et al. The relationship between premature ejaculation and hyperthyroidism. J Urol. 2009; 181(3): 1273–1280.
  8. McMahon CG, Jannini EA, Serefoglu EC, et al. The pathophysiology of acquired premature ejaculation. Transl Androl Urol. 2016; 5(4): 434–449.
  9. Carani C, Isidori AM, Granata A, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab. 2005; 90(12): 6472–6479.
  10. Krassas GE, Tziomalos K, Papadopoulou F, et al. Erectile dysfunction in patients with hyper- and hypothyroidism: how common and should we treat? J Clin Endocrinol Metab. 2008; 93(5): 1815–1819.
  11. Corona G, Wu FCW, Forti G, et al. EMAS Study Group. Thyroid hormones and male sexual function. Int J Androl. 2012; 35(5): 668–679.
  12. Veronelli A, Masu A, Ranieri R, et al. Prevalence of erectile dysfunction in thyroid disorders: comparison with control subjects and with obese and diabetic patients. Int J Impot Res. 2006; 18(1): 111–114.
  13. Abalovich M, Levalle O, Hermes R, et al. Hypothalamic-pituitary-testicular axis and seminal parameters in hyperthyroid males. Thyroid. 1999; 9(9): 857–863.
  14. Krysiak R, Drosdzol-Cop A, Skrzypulec-Plinta V, et al. Sexual function and depressive symptoms in young women with thyroid autoimmunity and subclinical hypothyroidism. Clin Endocrinol (Oxf). 2016; 84(6): 925–931.
  15. Jostel A, Ryder WD, Shalet SM. The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH Index. Clin Endocrinol (Oxf). 2009; 71(4): 529–534.
  16. Dietrich J, Landgrafe-Mende G, Wiora E, et al. Calculated Parameters of Thyroid Homeostasis: Emerging Tools for Differential Diagnosis and Clinical Research. Front Endocrinol. 2016; 7(57).
  17. Dietrich JW, Müller P, Schiedat F, et al. Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling. Eur Thyroid J. 2015; 4(2): 129–137.
  18. Rosen RC, Cappelleri JC, Gendrano N. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002; 14(4): 226–244.
  19. Cappelleri JC, Rosen RC, Smith MD, et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology. 1999; 54(2): 346–351.
  20. Krysiak R, Marek B, Okopień B. Sexual function and depressive symptoms in young men with hypothyroidism receiving levothyroxine/liothyronine combination therapy. Endokrynol Pol. 2018; 69(1): 16–22.
  21. Beck AT, Steer RA, Brown GK. BDI-II: Beck Depression Inventory Manual. 2nd ed. Psychological Corporation, San Antonio 1996.
  22. Krysiak R, Szwajkosz A, Marek B, et al. The effect of vitamin D supplementation on sexual functioning and depressive symptoms in young women with low vitamin D status. Endokrynol Pol. 2018; 69(2): 168–174.
  23. Krysiak R, Drosdzol-Cop A, Skrzypulec-Plinta V, et al. Sexual functioning and depressive symptoms in women with various types of prediabetes - a pilot study. Endokrynol Pol. 2018; 69(2): 175–181.
  24. American Psychiatric Association. Diagnostic and statistical manual of mental disorders — DSM-IV-TR. 4th ed. American Psychiatric Publishing, Washington 1994.
  25. Carosa E, Di Sante S, Rossi S, et al. Ontogenetic profile of the expression of thyroid hormone receptors in rat and human corpora cavernosa of the penis. J Sex Med. 2010; 7(4 Pt 1): 1381–1390.
  26. Hu CL, Wu YD, Liu HT, et al. [Effect of thyroid hormone on the contents of NOS and CO in the penile corpus cavernosum of rats]. Zhonghua Nan Ke Xue. 2009; 15(1): 37–40.
  27. Ozdemirci S, Yildiz F, Utkan T, et al. Impaired neurogenic and endothelium-dependent relaxant responses of corpus cavernosum smooth muscle from hyperthyroid rabbits. Eur J Pharmacol. 2001; 428(1): 105–111.
  28. La Vignera S, Vita R, Condorelli RA, et al. Impact of thyroid disease on testicular function. Endocrine. 2017; 58(3): 397–407.
  29. Shea JL, Wong PY, Chen Yu. Free testosterone: clinical utility and important analytical aspects of measurement. Adv Clin Chem. 2014; 63: 59–84.
  30. Corona G, Isidori AM, Aversa A, et al. Endocrinologic Control of Men's Sexual Desire and Arousal/Erection. J Sex Med. 2016; 13(3): 317–337.
  31. Smith TJ, Hegedüs L. Graves' Disease. N Engl J Med. 2016; 375(16): 1552–1565.
  32. Bové KB, Watt T, Vogel A, et al. Anxiety and depression are more prevalent in patients with graves' disease than in patients with nodular goitre. Eur Thyroid J. 2014; 3(3): 173–178.
  33. Senturk T, Kozaci LD, Kok F, et al. Proinflammatory cytokine levels in hyperthyroidism. Clin Invest Med. 2003; 26(2): 58–63.
  34. Postal M, Appenzeller S. The importance of cytokines and autoantibodies in depression. Autoimmun Rev. 2015; 14(1): 30–35.
  35. Biondi B, Wartofsky L. Treatment with thyroid hormone. Endocr Rev. 2014; 35(3): 433–512.
  36. Kłapcińska B, Poprzecki S, Danch A, et al. Selenium levels in blood of upper Silesian population: evidence of suboptimal selenium status in a significant percentage of the population. Biol Trace Elem Res. 2005; 108(1-3): 1–15.
  37. Szybiński Z. Polish Council for Control of Iodine Deficiency Disorders. Work of the Polish Council for Control of Iodine Deficiency Disorders, and the model of iodine prophylaxis in Poland. Endokrynol Pol. 2012; 63(2): 156–160.